Teacher Retirement System of Texas purchased a new stake in shares of Phreesia, Inc. (NYSE:PHR – Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 8,070 shares of the company’s stock, valued at approximately $206,000.
Several other institutional investors and hedge funds have also made changes to their positions in PHR. KBC Group NV acquired a new stake in Phreesia in the first quarter worth $74,000. Lisanti Capital Growth LLC acquired a new stake in Phreesia in the first quarter worth $1,062,000. Diversified Trust Co increased its position in Phreesia by 83.2% in the first quarter. Diversified Trust Co now owns 44,616 shares of the company’s stock worth $1,140,000 after buying an additional 20,260 shares during the period. Bessemer Group Inc. increased its position in Phreesia by 23.2% in the first quarter. Bessemer Group Inc. now owns 47,758 shares of the company’s stock worth $1,222,000 after buying an additional 8,978 shares during the period. Finally, Oppenheimer Asset Management Inc. acquired a new stake in Phreesia in the first quarter worth $205,000. 92.10% of the stock is owned by institutional investors and hedge funds.
Insider Buying and Selling
In other Phreesia news, Director Michael Weintraub sold 7,431 shares of the firm’s stock in a transaction dated Monday, June 9th. The stock was sold at an average price of $27.51, for a total transaction of $204,426.81. Following the completion of the sale, the director directly owned 143,039 shares in the company, valued at approximately $3,935,002.89. This trade represents a 4.94% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Lisa Egbuonu-Davis sold 2,802 shares of the firm’s stock in a transaction dated Thursday, June 26th. The stock was sold at an average price of $27.67, for a total value of $77,531.34. Following the sale, the director owned 22,037 shares of the company’s stock, valued at $609,763.79. The trade was a 11.28% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 45,987 shares of company stock worth $1,300,947. Company insiders own 5.50% of the company’s stock.
Wall Street Analysts Forecast Growth
Get Our Latest Analysis on Phreesia
Phreesia Trading Down 1.9%
Shares of PHR stock opened at $25.44 on Monday. The stock has a 50-day simple moving average of $26.50 and a 200 day simple moving average of $26.41. Phreesia, Inc. has a fifty-two week low of $17.07 and a fifty-two week high of $30.53. The stock has a market capitalization of $1.51 billion, a P/E ratio of -34.38 and a beta of 0.72. The company has a quick ratio of 1.95, a current ratio of 1.95 and a debt-to-equity ratio of 0.02.
Phreesia (NYSE:PHR – Get Free Report) last announced its earnings results on Wednesday, May 28th. The company reported ($0.07) earnings per share for the quarter, beating the consensus estimate of ($0.13) by $0.06. Phreesia had a negative return on equity of 16.23% and a negative net margin of 9.83%. The business had revenue of $115.94 million during the quarter, compared to analysts’ expectations of $115.00 million. During the same quarter last year, the business posted ($0.05) earnings per share. The company’s quarterly revenue was up 14.5% on a year-over-year basis. On average, sell-side analysts expect that Phreesia, Inc. will post -1.1 earnings per share for the current fiscal year.
Phreesia Company Profile
Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.
Further Reading
- Five stocks we like better than Phreesia
- 3 REITs to Buy and Hold for the Long Term
- 3 Streaming Stocks to Watch as Subscribers Drive Growth
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- America Wants Drone Dominance: Are These Stocks Ready to Soar?
- 3 Defense Stocks Set to Benefit From Increased Military Spending
- 3 Retailers Poised to Outmaneuver Tariff and Recession Concerns
Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.